IMR Press / CEOG / Volume 38 / Issue 4 / pii/1630543037366-1048474316

Clinical and Experimental Obstetrics & Gynecology (CEOG) is published by IMR Press from Volume 47 Issue 1 (2020). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on imrpress.com as a courtesy and upon agreement with S.O.G.

Original Research
Evaluation of clinical and cytogenetic findings on 1,068 second-trimester amniocenteses in Southeast Turkey
Show Less
1 Department of Medical Biology and Genetics, Medical Faculty, University of Dicle, Diyarbakir
2 Department of Gynecology and 0bstetrics Medical Faculty, University of Dicle, Diyarbakir (Turkey)
Clin. Exp. Obstet. Gynecol. 2011, 38(4), 364–368;
Published: 10 December 2011
Abstract

Objective: To investigate the indications of amniocentesis for the detection of chromosomal abnormalities among a sample of patients in Southeast Turkey. Material and Methods: Between 2004 and 2007, 1,068 second-trimester amniocentesis tests were per-formed in the Medical Biology and Genetics Department Laboratory at Dicle University. Amniotic fluids were cultured by using long-term tissue culture for prenatal diagnosis with cytogenetic analysis. The clinical and cytogenetic findings on 1,068 second-trimester amniocenteses were analyzed. The indications, the proportions of karyotypes according to indications and complications were summarized. Results: Among the 1,068 amniocentesis cases, the maternal age between 35 and 39 years was the most commonage group (34.5%). Of the clinical indications abnormal maternal serum screening results were the most common indication for amniocentesis(37.6%). Of 52 cases (4.9%) with detected chromosomal aberrations, 39 were numeric (27 trisomies, 10 sex chromosome aberrations and two triploidies) and 13 were structural (2 reciprocal translocations, 2 Robertsonian translocations and 6inversions). The highest detection rate of chromosome aberrations was in cases undergoing amniocentesis for abnormal maternal serum screening combined with abnormal ultrasound (US) findings (8.0%). Conclusion: This study suggests that complementary measures, such as routine antenatal US and maternal serum screening, should be added to increase the efficiency of genetic amniocentesis. Therefore, the study could be used for the establishment of a database for genetic counseling.
Keywords
Amniocentesis
Chromosome aberrations
Genetic counseling
Prenatal diagnosis
Share
Back to top